Hillsdale, NJ, United States of America

Henry B Abajian


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1996-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Henry B Abajian

Introduction

Henry B Abajian is a notable inventor based in Hillsdale, NJ (US). He has made significant contributions to the field of therapeutic peptides, holding a total of 8 patents. His work focuses on novel uses of peptides to address various neurological and psychiatric disorders.

Latest Patents

Abajian's latest patents include groundbreaking research on the therapeutic uses of tri-, tetra-, penta-, and polypeptides. These inventions disclose novel applications of certain peptides, particularly the tripeptide hormone MIF, to treat patients suffering from neurological or psychiatric disorders. The patents detail modifications of MIF, including changes to amino terminus residues, carboxyl terminus residues, and internal residues. These modifications may involve the addition and substitution of amino acid residues, as well as alterations to peptide bonds and functional side groups. The tri-, tetra-, penta-, peptides, and polypeptides can be utilized alone or in combination with other agents to treat patients with various physiological, psychosomatic, neurological, or psychiatric disorders. Another significant patent focuses on the use of these novel peptides to treat patients suffering from depression, emphasizing the therapeutic potential of modified MIF.

Career Highlights

Henry B Abajian is associated with Innapharma, Inc., where he continues to innovate in the field of peptide therapeutics. His extensive research and development efforts have positioned him as a key figure in the advancement of treatments for mental health conditions.

Collaborations

Abajian has collaborated with notable colleagues, including Joseph J Hlavka and John Fowler Noble, contributing to the collective expertise in his field.

Conclusion

Henry B Abajian's work in the development of therapeutic peptides showcases his commitment to improving treatments for neurological and psychiatric disorders. His innovative patents reflect a significant advancement in medical science, offering hope for patients suffering from these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…